Lung bioavailability of hydrofluoroalkane fluticasone in young children when delivered by an antistatic chamber/mask
Authors:
- Yufei TangYTYufei Tang
- Guenther HochhausGHGuenther Hochhaus
- Jonathan J. ShusterJSJonathan J. Shuster
- Terry SpencerTSTerry Spencer
- Sarah ChesrownSCSarah Chesrown
- Leslie HendelesLHLeslie Hendeles
- 1 December 2006
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 149 (6) , 793-797
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Fluticasone propionate plasma concentration and systemic effect: Effect of delivery device and duration of administrationJournal of Allergy and Clinical Immunology, 2005
- Side-effects of fluticasone in asthmatic children: no effects after dose reductionEuropean Respiratory Journal, 2004
- Spacer Devices for Metered Dose InhalersClinical Pharmacokinetics, 2004
- Safety of inhaled corticosteroids delivered by plastic and metal spacersArchives of Disease in Childhood, 2003
- Plasma concentrations of fluticasone propionate and budesonide following inhalation from dry powder inhalers by healthy and asthmatic subjectsThorax, 2003
- Persistent wheezing in infants with an atopic tendency responds to inhaled fluticasoneArchives of Disease in Childhood, 2001
- Variability of aerosol delivery via spacer devices in young asthmatic children in daily lifeEuropean Respiratory Journal, 1999
- Deposition pattern of radiolabeled salbutamol inhaled from a metered-dose inhaler by means of a spacer with mask in young children with airway obstructionThe Journal of Pediatrics, 1996
- A non-electrostatic spacer for aerosol delivery.Archives of Disease in Childhood, 1995
- Choosing the metered-dose inhaler spacer or holding chamber that matches the patient's need: Evidence that the specific drug being delivered is an important considerationJournal of Allergy and Clinical Immunology, 1995